Shukra Pharmaceuticals Share Price
25 Sep, 2026 4:01 PM (IST)
Shukra Pharmaceuticals Performance
- Today's Low
- ₹56
- Today's High
- ₹58
- 52 Week Low
- ₹26
- 52 Week High
- ₹65
- Open Price₹58
- Previous Close₹56
- Volume2,004,513
- 50 DMA₹46.00
- 100 DMA₹41.30
- 200 DMA₹37.90
Shukra Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 26.29%
- Over 3 Month + 89.61%
- Over 6 Month + 68.97%
- Over 1 Year + 62.01%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 72.3
- PEG Ratio
- 0.3
- Market Cap Cr
- 2,456
- P/B Ratio
- 23.8
- Average True Range
- 2.8
- EPS
- 0.8
- Dividend Yield
- 0
- MACD Signal
- 3.8
- RSI
- 66.42
- MFI
- 43.53
Latest Stock News Updates
Closure of Trading Window
- BSE India
- 2 days 21 hours ago
Newspaper Publication
- BSE India
- 4 days ago
Corrigendum to Post Ballot Notice
- BSE India
- 4 days 21 hours ago
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹52.70
- 50 Day
- ₹46.00
- 100 Day
- ₹41.30
- 200 Day
- ₹37.90
Resistance and Support
- R3 59.10
- R2 58.40
- R1 57.10
- S1 55.20
- S2 54.50
- S3 53.20
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-22 | A.G.M. | |
| 2026-08-12 | Quarterly Results | |
| 2026-06-10 | Others | Inter-alia, to consider 1. Ratification of Approval for member's resolution passed in the EGM. 2. To approve draft of notice of postal ballot. 3. Other business matters. |
| 2026-05-07 | Audited Results & Final Dividend | |
| 2026-03-16 | Others | Inter-alia, to consider 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To Review the performance of the Chairman of the Company. 3. Other business matters. |
About Shukra Pharmaceuticals
Shukra Pharmaceuticals is engaged in the manufacturing, marketing, and export of pharmaceutical formulations. The Company caters to both domestic and international markets, with a growing presence in countries such as Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen. View More- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Popular Stocks
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹55 As on 27 September, 2026 | 16:11
The Market Cap of Shukra Pharmaceuticals is ₹2455.7 Cr As on 27 September, 2026 | 16:11
The P/E ratio of Shukra Pharmaceuticals is 72.3 As on 27 September, 2026 | 16:11
The PB ratio of Shukra Pharmaceuticals is 23.8 As on 27 September, 2026 | 16:11
The 52 week High & Low of Shukra Pharmaceuticals is ₹65.3/₹26.3 respectively As on 27 September, 2026 | 16:11
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.